A
BPMC

AlphaQuest’s Blueprint Medicines BPMC Stock Holding History

AlphaQuest’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,623
Closed -$208K – 2242
2025
Q2 		$208K Sell
1,623
-110
-6% -$11.4K 0.02% 1104
2025
Q1 		$153K Buy
1,733
+1,638
+1,724% +$160K 0.02% 1111
2024
Q4 		$8.29K Sell
95
-1,457
-94% -$133K ﹤0.01% 1501
2024
Q3 		$144K Sell
1,552
-119
-7% -$11.8K 0.01% 1194
2024
Q2 		$180K Sell
1,671
-27
-2% -$2.7K 0.02% 780
2024
Q1 		$161K Buy
+1,698
New +$146K 0.03% 713

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

AlphaQuest's BPMC Position: Q3 2025 in Review

AlphaQuest sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 1,623 shares — an estimated $208K sold.

AlphaQuest first reported a position in BPMC in Q1 2024 and held it in 6 quarters. The position peaked at $208K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • AlphaQuest reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • AlphaQuest sold 1,623 Blueprint Medicines shares in Q3 2025, an estimated $208K.
  • AlphaQuest first reported a position in Blueprint Medicines in Q1 2024 and held it in 6 quarters.
  • AlphaQuest's Blueprint Medicines position peaked at $208K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on AlphaQuest's 13F filing for Q3 2025, filed 3 Nov 2025.